Prior Authorization
Requiring prescribers to obtain advance approval before insurance will cover HCV treatment
REPORT CARDS
Find your state below and check out our 2025 National Snapshot Report.
DISCRIMINATORY STATE MEDICAID RESTRICTIONS
While there have been some improvements in both state Medicaid program transparency and access since 2014, most states still have discriminatory restrictions that keep patients from being cured. Here are the restrictions that are the most significant barriers to HCV treatment:
Fibrosis Restrictions
Based on a patient’s degree of liver damage or fibrosis level
Substance Use Restrictions
Based on a patient’s drug or alcohol use
Prescriber Restrictions
Based on a prescriber’s specialty or expertise
Retreatment Restrictions
Based on whether a patient has previously received treatment
Access in Managed Care
Assesses parity between a state’s fee-for-service program and contracted managed care organizations
Additional Restrictions
Restrictions that are less common but may pose severe barriers to care
Find Your State
*States with an asterisk next to their grade have removed prior authorization for most patients entirely